PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 17192628-3 2006 Furthermore, it seems that activation of alpha7 nAChR is the mechanism by which galantamine protects against thapsigargin and beta-amyloid-induced cell death (Arias et al., 2004), as well as in neuroprotection exerted by NIC against tumor necrosis factor alpha (Gahring et al., 2003). Galantamine 80-91 tumor necrosis factor Mus musculus 233-260 18639629-5 2009 Peripheral administration of the acetylcholinesterase inhibitor galantamine significantly reduced serum TNF levels through vagus nerve signaling, and protected against lethality during murine endotoxemia. Galantamine 64-75 tumor necrosis factor Mus musculus 104-107 18639629-6 2009 Administration of a centrally-acting muscarinic receptor antagonist abolished the suppression of TNF by galantamine, indicating that suppressing acetylcholinesterase activity, coupled with central muscarinic receptors, controls peripheral cytokine responses. Galantamine 104-115 tumor necrosis factor Mus musculus 97-100 30586550-6 2019 Interestingly, daily intraperitoneal administration of galantamine, an inhibitor of acetylcholinesterase, reversed cognitive dysfunction in surgery mice and attenuated accumulation of microglia and protein levels of IL-1beta, IL-6 and TNF-alpha in the hippocampus. Galantamine 55-66 tumor necrosis factor Mus musculus 235-244 31024522-4 2019 Forebrain-selective genetic ablation of acetylcholine release and vagotomy abolished the suppression of serum TNF by the centrally-acting cholinergic drug galantamine in murine endotoxemia. Galantamine 155-166 tumor necrosis factor Mus musculus 110-113 26521029-7 2015 Galantamine reduced the total area of amyloid load within the hippocampus of transgenic APP/PS1 mice, inhibited astrocyte activation as assessed by immunohistochemistry and decreased intracellular TNF-alpha and IL-6 expression as determined by immunofluorescence. Galantamine 0-11 tumor necrosis factor Mus musculus 197-206 29669582-10 2018 Galantamine decreased the expression of microglia and astrocyte markers (CD11b and GFAP), pro-inflammatory cytokines (IL-1beta, IL-6, and TNF-alpha), and NF-kappaB p65 in the hippocampus of LPS-exposed mice. Galantamine 0-11 tumor necrosis factor Mus musculus 138-147